Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Almirall, S.A., Ronda General Mitre 151, 08022 Barcelona, Spain
Meptid 100mg/ml Solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear colourless solution free from particulate matter. |
Each 1 ml of solution contains 100mg of meptazinol (as hydrochloride).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Meptazinol |
Meptazinol is a centrally acting analgesic belonging to the hexahydroazepine series, which has demonstrated mixed agonist and antagonist activity at opioid receptors. It is used for the short term treatment of moderate pain. |
| List of Excipients |
|---|
|
Glucose |
1 ml clear glass ampoules. The glass complies with the requirements of the European Pharmacopoeia Type I. The ampoules will be packed in cartons of 10.
Not all pack sizes may be marketed.
Almirall, S.A., Ronda General Mitre 151, 08022 Barcelona, Spain
PL 16973/0018
16 December 1992/12 October 2005
| Drug | Countries | |
|---|---|---|
| MEPTID | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
